With annual sales of cosmetic wrinkle fillers amounting to an average $450 million worldwide, Anika has hit pay dirt. The Company has been granted conditional approval from the Food & Drug Administration (FDA) for its new anti-aging product, an injectible wrinkle filler. The filler is said to be usable for lip augmentation as well for treating scars.   Customers can expect to see the product on the market sometime in mid-2007.

The announcement resulted in the Anika’s share jumping on Nasdag moving from $3.73 per share to $15.29. Anika representative said final approval is expected shortly.